MF
MFGenie.ai
Sectoral / Thematic📊 BSE Healthcare TRI

ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth

ICICI Prudential Mutual Fund

NAV

₹48.2700

as of 18 Nov 2026

Expense Ratio

—

see scheme documents

Viewing Direct · Growth
Risk-o-meter: not yet available here. See the latest risk-o-meter in the fund house's official disclosure.
Compare Fund

Lumpsum returns (CAGR)

1Y
+9.05%
3Y
+21.40%
5Y
+18.15%
Since Inception
+20.69%

SIP returns (XIRR)

1Y
+17.31%
3Y
+14.68%
5Y
+20.28%
Since Inception
+21.48%

Performance Comparison

Sectoral allocation

as of 30 Jun 2026

Each sector links to the mutual funds most exposed to it.

Thinking about ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth?

Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.

+91

By submitting, you agree to our Privacy Policy. No spam, ever.

Fund Details

Fund HouseICICI Prudential Mutual Fund
CategorySectoral / Thematic
BenchmarkBSE Healthcare TRI
Launch Date13 Jul 2018
AMFI Code143874
Transaction facts
Min. Lumpsum₹5,000
Min. SIP₹100
Exit LoadNil

Available transactions

PurchaseSIPRedeemSWPSwitchSTPDemat

Portfolio holdings

as of 31 Jul 2026

portfolio shared with ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option

Holding% NAV

What this fund does

ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.

About This Fund

ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by ICICI Prudential Mutual Fund. The fund has been operational for over 8 years. It benchmarks its performance against BSE Healthcare TRI.

Invest Online